Scientific Program for Wednesday September 16th, 2015
Theme: Evolving concepts in pathogenesis, clinic and therapy of the porphyrias / Miscellaneous
Session 9
Chair: Aasne K. Arsand (Norway) and Robert J. Desnick (USA)
09:00 - 09:45
Plenary lecture 8: »The role of cellular metabolites in heme synthesis.«
Harry A. Dailey, USA
09:45 - 10:45
Selected oral presentations
26. Molecular and kinetic characterisation of wild type and mutant human porphobilinogen deaminase.
Elaine Pienaar et al., South Africa
27. Markers of endothelial dysfunction in patients with acute porphyrias.
Paolo Ventura et al., Italy
28. Systemic inflammation revealed by plasma biomarkers in acute intermittent porphyria.
Ole-Lars Brekke et al., Norway
29. Psychosocial issues in acute porphyria: A qualitative study of the perspectives of patients.
Hetanshi Naik et al., USA
10:45 - 11:15
Coffee break
Session 10
Chair: Laurent Gouya (France) and Alcira Batlle (Argentina)
11:15 - 12:00
Plenary lecture 9: »A paradigm shift in understanding porphyrias: prospecting for drug innovations and disease outcomes through the lens of structural biology.«
C.S. Raman, USA
12:00 - 12:45
Selected oral presentations
30. Characterisation of the functional role of variants within the regulatory regions of UROD and CPOX genes.
Valeria Fiorentino et al., Italy
31. Non-invasive measurement of mitochondrial health in porphyria.
Ashwani Singal et al., USA
32. Dental health in acute intermittent porphyria: a case control study.
Elin Storjord et al., Norway
12:45 - 13:00
Future meetings / Closing remarks / Farewell and end of the meeting
